Relationship between ADIPOQ gene, circulating high molecular weight adiponectin and albuminuria in individuals with normal kidney function: Evidence from a family-based study

Diabetologia

Volumn 54, Issue 4, 2011, Pages 812-818

  Menzaghi, C ^a   De Cosmo, S ^a   Copetti, M ^a   Salvemini, L ^a   De Bonis, C ^a   Mangiacotti, D ^a   Fini, G ^a   Pellegrini, F ^a   Trischitta, V ^a,b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adiponectin HMW; ADIPOQ gene; Albuminuria; Mendelian randomisation

Indexed keywords

ADIPONECTIN; ALBUMIN; CREATININE;

ADIPOQ GENE; ADOLESCENT; ADULT; AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; EVIDENCE BASED MEDICINE; FAMILY STUDY; FEMALE; GENE; GENETIC CORRELATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CREATININE; CYSTATIN C; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NEPHELOMETRY AND TURBIDIMETRY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; YOUNG ADULT;

EID: 79953816968     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-2037-9     Document Type: Article

References (50)

1. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430-1432 (Pubitemid 12123979)
2. Valmadrid CT, Klein R, Moss SE, Klein BE (2000) The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 160:1093-1100 (Pubitemid 30227018)
3. Hillege HL, Fidler V, Diercks GF et al (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777-1782
4. Scherer PE (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55:1537-1545
5. Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE (2008) Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 149:2270-2282 (Pubitemid 351574488)
6. Kadowaki T, YamAUChi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439-451 (Pubitemid 40686653)
7. Heidemann C, Sun Q, van Dam RM et al (2008) Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 149:307-316
8. Spranger J, Kroke A, Mohlig M et al (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226-228 (Pubitemid 36126226)
9. Weyer C, Funahashi T, Tanaka S et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935 (Pubitemid 32472900)
10. Chen J, Muntner P, Hamm LL et al (2004) The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140:167-174
11. De Cosmo S, Trevisan R, Minenna A et al (2006) Insulin resistance and the cluster of abnormalities related to the metabolic syndrome are associated with reduced glomerular filtration rate in patients with type 2 diabetes. Diabetes Care 29:432-434 (Pubitemid 44106535)
12. Looker HC, Krakoff J, Funahashi T et al (2004) Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes. J Clin Endocrinol Metab 89:4010-4017 (Pubitemid 39071508)
13. Hadjadj S, Aubert R, Fumeron F et al (2005) Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects. Diabetologia 48:1088-1092 (Pubitemid 40909643)
14. Komaba H, Igaki N, Goto S et al (2006) Increased serum high molecular weight complex of adiponectin in type 2 diabetic patients with impaired renal function. Am J Nephrol 26:476-482 (Pubitemid 44971739)
15. Leth H, Andersen KK, Frystyk J et al (2008) Elevated levels of high molecular weight adiponectin in type 1 diabetes. J Clin Endocrinol Metab 93:3186-3191
16. Jorsal A, Tarnow L, Frystyk J et al (2008) Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int 74:649-654
17. Saraheimo M, Forsblom C, Thorn L et al (2008) Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care 31:1165-1169
18. Jaziri R, Aubert R, Roussel R et al (2010) Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes. Nephrol Dial Transplant 25:2231-2237
19. von Eynatten M, Schneider JG, Hadziselimovic S et al (2005) Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes. Diabetes Care 28:754-755 (Pubitemid 40315347)
20. von Eynatten M, Liu D, Bluemm A et al (2009) Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes. Clin Endocrinol (Oxf) 71:27-32
21. Strippoli GF, Navaneethan SD, Johnson DW et al (2008) Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ 336:645-651 (Pubitemid 351481234)
22. Ruggenenti P, Cravedi P, Remuzzi G, Medscape (2010) The RAAS in the pathogenesis and treatment of diabetic nephropathy. Nat Rev Nephrol 6:319-330
23. Pajvani UB, Hawkins M, Combs TP et al (2004) Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279:12152-12162 (Pubitemid 38445780)
24. Sarafidis PA, Stafylas PC, Georgianos PI, Saratzis AN, Lasaridis AN (2010) Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis. Am J Kidney Dis 55:835-847
25. Menzaghi C, Trischitta V, Doria A (2007) Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 56:1198-1209 (Pubitemid 46715598)
26. Hivert MF, Manning AK, McAteer JB et al (2008) Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 57:3353-3359
27. Richards JB, Waterworth D, O'Rahilly S et al (2009) A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 5:e1000768
28. Heid IM, Henneman P, Hicks A et al (2010) Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 208:412-420
29. Tian C, Plenge RM, Ransom M et al (2008) Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genet 4:e4
30. Menzaghi C, Ercolino T, Salvemini L et al (2004) Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13. Physiol Genomics 19:170-174 (Pubitemid 40039923)
31. Menzaghi C, Coco A, Salvemini L et al (2006) Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab 91:2792-2795 (Pubitemid 44024653)
32. Menzaghi C, Salvemini L, Paroni G et al (2010) Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family-based study. J Intern Med 267:287-294
33. Placha G, Poznik GD, Dunn J et al (2006) A genome-wide linkage scan for genes controlling variation in renal function estimated by serum cystatin C levels in extended families with type 2 diabetes. Diabetes 55:3358-3365 (Pubitemid 44923593)
34. Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Gen 62:1198-1211 (Pubitemid 28199022)
35. Didelez V, Sheehan N (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16:309-330 (Pubitemid 47215256)
36. Snijders TAB, Bosker R (1999) Multilevel analysis: an introduction to basic and advanced multilevel modeling. Sage, London
37. van Houwelingen HC, Arends LR, Stijnen T (2002) Advanced methods in meta-analysis: multivariate approach and metaregression. Stat Med 21:589-624
38. Tentolouris N, Doulgerakis D, Moyssakis I et al (2004) Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease. Horm Metab Res 36:721-727 (Pubitemid 39486974)
39. Tsioufis C, Dimitriadis K, Chatzis D et al (2005) Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 96:946-951 (Pubitemid 41362518)
40. Sharma K, Ramachandrarao S, Qiu G et al (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118:1645-1656 (Pubitemid 351632369)
41. Vionnet N, Tregouët D, Kazeem G et al (2006) Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes 55:3166-3174 (Pubitemid 44923657)
42. Bouatia-Naji N, Meyre D, Lobbens S et al (2006) ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 55:545-550 (Pubitemid 43343288)
43. Laumen H, Saningong AD, Heid IM et al (2009) Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 58:984-991
44. Morris NJ, Gray-McGuire C, Stein CM (2009) Mendelian randomization in family data. BMC Proc 3(Suppl 7):S45
45. Krolewski AS, Poznik GD, Placha G et al (2006) A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 69:129-136 (Pubitemid 43117748)
46. Mottl AK, Vupputuri S, Cole SA et al (2009) Linkage analysis of albuminuria. J Am Soc Nephrol 20:1597-1606
47. Gu HF, Alvarsson A, Efendic S, Brismar K (2009) SOX2 has gender-specific genetic effects on diabetic nephropathy in samples from patients with type 1 diabetes mellitus in the GoKinD study. Gend Med 6:555-564
48. Beige J, Heipmann K, Stumvoll M, Körner A, Kratzsch J (2009) Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology. Expert Opin Ther Targets 13:163-173
49. Zoccali C, Mallamaci F, Tripepi G et al (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13:134-141 (Pubitemid 34042020)
50. Zoccali C, Mallamaci F, Tripepi G (2004) Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease. Nephrol Dial Transplant 19(Suppl 5):V67-V72 (Pubitemid 39214203)